Ma J - Search Results

1

Ribociclib in hormone-receptor-positive advanced breast cancer: Establishing a value-based cost in China.

Wan X, Zhang Y, Ma J, Tan C, Zeng X, Peng L. Wan X, et al. Among authors: ma j. Breast. 2019 Feb;43:1-6. doi: 10.1016/j.breast.2018.10.004. Epub 2018 Oct 16. Breast. 2019. PMID: 30342258

2

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.

Wan X, Peng L, Ma J, Chen G, Li Y. Wan X, et al. Among authors: ma j. Clin Ther. 2015 Nov 1;37(11):2515-2526.e5. doi: 10.1016/j.clinthera.2015.09.007. Epub 2015 Oct 21. Clin Ther. 2015. PMID: 26475419

3

Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives.

Wan XM, Peng LB, Ma JA, Li YJ. Wan XM, et al. Cancer. 2017 Jul 15;123(14):2634-2641. doi: 10.1002/cncr.30666. Epub 2017 Mar 16. Cancer. 2017. PMID: 28301684 Free article.

4

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments.

Zhao X, Zhang N, Zhang H, Liu P, Ma J, Hu C, Liu X, Hou T. Zhao X, et al. Among authors: ma j. Medicine (Baltimore). 2020 Nov 13;99(46):e23150. doi: 10.1097/MD.0000000000023150. Medicine (Baltimore). 2020. PMID: 33181687 Free PMC article.

5

Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients.

Deng C, Zhang N, Jiang S, Zhang H, Ma J, Zou W, Liu X, Hu C, Hou T. Deng C, et al. Among authors: ma j. Sci Rep. 2022 Jul 13;12(1):11978. doi: 10.1038/s41598-022-16216-0. Sci Rep. 2022. PMID: 35831424 Free PMC article.

6

Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel.

Guo L, Peng H, Cai HL, Tang D, Hu H, Wang F, Liu J, Que KL, Han C, Zhang Y, Yan M, Ma JA. Guo L, et al. Among authors: ma ja. Cancer Chemother Pharmacol. 2019 Apr;83(4):727-734. doi: 10.1007/s00280-019-03777-7. Epub 2019 Jan 24. Cancer Chemother Pharmacol. 2019. PMID: 30680523 Clinical Trial.

7

Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report.

Zou F, Xie G, Ma JA, Zhou DA, Jiang YI, Zheng JY. Zou F, et al. Oncol Lett. 2015 May;9(5):2239-2243. doi: 10.3892/ol.2015.3057. Epub 2015 Mar 18. Oncol Lett. 2015. PMID: 26137049 Free PMC article.

8

[Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer].

Luo D, Ma J, Zhang J, Zhao Y. Luo D, et al. Among authors: ma j. Zhongguo Fei Ai Za Zhi. 2017 Jun 20;20(6):415-420. doi: 10.3779/j.issn.1009-3419.2017.06.08. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28641700 Free PMC article. Review. Chinese.

9

Synchronous colorectal cancer and multiple myeloma with chest wall involvement: Is this a coincidence?

Li QL, Ma JA, Li HP, Huang RB, Hu CH, Liu XL, Gao YW, Feng GH, Wu F. Li QL, et al. Curr Probl Cancer. 2017 Nov-Dec;41(6):413-418. doi: 10.1016/j.currproblcancer.2017.09.002. Epub 2017 Sep 25. Curr Probl Cancer. 2017. PMID: 29129340 Review.

10

Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer.

Wu F, Liu X, Ma JA, Gao Y, Hu C. Wu F, et al. Lancet Oncol. 2018 Mar;19(3):e124. doi: 10.1016/S1470-2045(18)30073-1. Lancet Oncol. 2018. PMID: 29508749 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,336 results

Search Page

Filters